[Federal Register Volume 77, Number 102 (Friday, May 25, 2012)]
[Notices]
[Pages 31388-31389]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2012-12813]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Importer of Controlled Substances; Notice of Registration; 
Meridian Medical Technologies

    By Notice dated March 23, 2012, and published in the Federal 
Register on April 2, 2012, 77 FR 19716, Meridian Medical Technologies, 
2555 Hermelin Drive, St. Louis, Missouri 63144, made application by 
renewal to the Drug Enforcement Administration (DEA) to

[[Page 31389]]

be registered as an importer of Morphine (9300), a basic class of 
controlled substance listed in schedule II.
    The company manufactures a product containing morphine in the 
United States. The company exports this product to customers around the 
world, including Europe. The company has been asked to ensure that its 
product sold to European customers meets standards established by the 
European Pharmacopeia, which is administered by the Directorate of the 
Quality of Medicines (EDQM). In order to ensure that its product will 
meet European specifications, the company seeks to import morphine 
supplied by EDQM to use as reference standards. This is the sole 
purpose for which the company will be authorized by DEA to import 
morphine.
    No comments or objections have been received. DEA has considered 
the factors in 21 U.S.C. 823(a) and 952(a), and determined that the 
registration of Meridian Medical Technologies to import the basic class 
of controlled substance is consistent with the public interest and with 
United States obligations under international treaties, conventions, or 
protocols in effect on May 1, 1971. DEA has investigated Meridian 
Medical Technologies to ensure that the company's registration is 
consistent with the public interest. The investigation has included 
inspection and testing of the company's physical security systems, 
verification of the company's compliance with state and local laws, and 
a review of the company's background and history.
    Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in 
accordance with 21 CFR 1301.34, the above named company is granted 
registration as an importer of the basic class of controlled substances 
listed.

     Dated: May 15, 2012.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 2012-12813 Filed 5-24-12; 8:45 am]
BILLING CODE 4410-09-P